Israel Englander Millennium Management
Israel “Izzy” Englander is the founder of Millennium Management, one of the world’s largest multi-strategy hedge fund platforms. Millennium allocates capital across hundreds of independent teams rather than a single house view, with rigorous risk controls at the platform level. Englander’s model has been highly influential in the rise of pod-shop multi-manager structures across the industry.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$643M |
| 2 |
AT&T
T
|
+$311M |
| 3 |
State Street Technology Select Sector SPDR ETF
XLK
|
+$306M |
| 4 |
Microsoft
MSFT
|
+$292M |
| 5 |
Ametek
AME
|
+$215M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
ALXN
Alexion Pharmaceuticals
ALXN
|
+$887M |
| 2 |
Apple
AAPL
|
+$694M |
| 3 |
PRAH
PRA Health Sciences, Inc.
PRAH
|
+$616M |
| 4 |
Amazon
AMZN
|
+$596M |
| 5 |
Linde
LIN
|
+$531M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 7.69% |
| 2 | Financials | 6.83% |
| 3 | Healthcare | 6.42% |
| 4 | Industrials | 4.98% |
| 5 | Consumer Discretionary | 4.41% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
976
Dropbox
DBX
$7.58B
| $29.5M | 0.02% |
1,010,175
-308,398
| -23% | -$9.58M |
|
977
CALL
Dow Inc
DOW
$22.7B
| $29.5M | 0.02% |
512,400
+362,400
| +242% | +$22.2M |
|
978
CALL
Gilead Sciences
GILD
$182B
| $29.4M | 0.02% |
421,200
| – | – |
|
979
Oshkosh
OSK
$9.65B
| $29.4M | 0.02% |
287,344
+259,008
| +914% | +$29.8M |
|
980
Ascendis Pharma A/S
ASND
$16.5B
| $29.4M | 0.02% |
184,384
+175,906
| +2,075% | +$24.1M |
|
981
Wynn Resorts
WYNN
$10.2B
| $29.4M | 0.02% |
346,394
+257,199
| +288% | +$25.4M |
|
982
Royal Caribbean
RCL
$78.4B
| $29.3M | 0.02% |
329,839
+281,229
| +579% | +$22.7M |
|
|
TGNA
983
DELISTED
TEGNA Inc
TGNA
| $29.3M | 0.02% |
1,484,795
+171,314
| +13% | +$3.11M |
|
984
Illinois Tool Works
ITW
$80.9B
| $29.3M | 0.02% |
141,576
-437,328
| -76% | -$98.6M |
|
985
Starbucks
SBUX
$123B
| $29.1M | 0.02% |
264,183
-547,874
| -67% | -$64.1M |
|
|
CONX
986
DELISTED
CONX Corp. Class A Common Stock
CONX
| $29.1M | 0.02% |
2,973,510
| – | – |
|
987
PUT
United States Oil Fund
USO
$2.07B
| $29M | 0.02% |
552,300
+450,000
| +440% | +$22M |
|
|
WPCB
988
DELISTED
Warburg Pincus Capital Corporation I-B
WPCB
| $29M | 0.02% |
2,965,986
+1,312,512
| +79% | +$12.8M |
|
|
COWN
989
DELISTED
Cowen Inc. Class A Common Stock
COWN
| $29M | 0.02% |
845,444
+341,470
| +68% | +$12.8M |
|
990
PUT
Exelon
EXC
$45.7B
| $29M | 0.02% |
841,200
+560,800
| +200% | +$19.2M |
|
|
EXE
991
Expand Energy Corp
EXE
$22.3B
| $28.9M | 0.02% |
+469,937
| New | +$26.3M |
|
992
LKQ Corp
LKQ
$6.51B
| $28.9M | 0.02% |
574,560
+195,363
| +52% | +$9.94M |
|
993
CALL
iShares Biotechnology ETF
IBB
$10.7B
| $28.8M | 0.02% |
178,100
+128,400
| +258% | +$21.6M |
|
994
Vipshop
VIPS
$6.88B
| $28.8M | 0.02% |
2,584,107
-2,010,454
| -44% | -$31.6M |
|
|
SEAH
995
DELISTED
Sports Entertainment Acquisition Corp.
SEAH
| $28.7M | 0.02% |
2,860,527
+803,581
| +39% | +$8M |
|
|
ATC
996
DELISTED
Atotech Limited
ATC
| $28.6M | 0.02% |
1,186,320
+1,098,677
| +1,254% | +$26.4M |
|
997
Commercial Metals
CMC
$7.18B
| $28.6M | 0.02% |
939,854
+845,393
| +895% | +$26.9M |
|
998
Vertiv
VRT
$98.2B
| $28.6M | 0.02% |
1,188,233
+990,517
| +501% | +$26.3M |
|
999
Agree Realty
ADC
$9.28B
| $28.6M | 0.02% |
431,140
+104,488
| +32% | +$7.61M |
|
1000
Johnson Controls International
JCI
$86.6B
| $28.5M | 0.02% |
418,856
-1,753,397
| -81% | -$127M |
|
Similar funds
Israel Englander's Q3 2021 Portfolio in Review
As of Q3 2021, Israel Englander held 7,698 positions worth $167B, up 2.3% from $163B the previous quarter. Its ten largest holdings account for 18% of the portfolio.
Israel Englander deployed $8.65B of net new capital in Q3 2021, opening 1,245 new positions and adding to 2,719 existing holdings. Its largest new stake was Sight Sciences: 1,577,092 shares worth $35.8M.
By sector, the portfolio is most concentrated in Technology at 7.7% of assets, down from 8.2% a quarter earlier, followed by Financials and Healthcare.
On the sell side, the largest reduction was Apple, an estimated $694M trimmed.
- Israel Englander's largest Q3 2021 buy was Sight Sciences: 1,577,092 shares worth $35.8M.
- Israel Englander added most to State Street SPDR S&P 500 ETF Trust in Q3 2021, an estimated $643M increase.
- Israel Englander's biggest Q3 2021 reduction was Apple, cutting an estimated $694M.
- Israel Englander fully exited Alexion Pharmaceuticals in Q3 2021, selling an estimated $887M.
- Israel Englander's ten largest holdings make up 18% of its $167B portfolio in Q3 2021.
- Israel Englander opened 1,245 new positions and closed 981 in Q3 2021.
- Israel Englander's portfolio value rose 2.3% quarter-over-quarter to $167B.
Based on Millennium Management's 13F filing for Q3 2021, filed 15 Nov 2021.